Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Asensus Surgical Inc (ASXC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Asensus Surgical's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.249 +0.008    +3.32%
27/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.242
-0.008
-3.200%
8:48:08 - Real-time Data
  • Volume: 610,940
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.239 - 0.250
Type:  Equity
Market:  United States
Asensus Surgical 0.249 +0.008 +3.32%

Asensus Surgical Inc Company Profile

 
Get an in-depth profile of Asensus Surgical Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

190

Equity Type

ORD

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company’s products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Contact Information

Address 1 TW Alexander Drive Suite 160
Durham, 27703
United States
Phone 919 765 8400
Fax 919 765 8459

Top Executives

Name Age Since Title
Aurora Pryor - - Member of Advisory Board
David B. Milne 61 2013 Independent Chairman
William N. Starling 70 2013 Independent Director
David M. Albala - - Member of Advisory Board
Craig Sobolewski - - Member of Advisory Board
Paresh C. Shah - - Member of Advisory Board
Nathaniel J. Soper - - Member of Advisory Board
W. Scott Melvin - - Member of Advisory Board
David W. Rattner - - Member of Advisory Board
Jose Martinez - - Member of Advisory Board
Steve Eubanks - - Member of Advisory Board
Richard C. Pfenniger 68 2005 Independent Director
Anthony Fernando 51 2015 President, CEO & Director
Andrea Biffi 41 2015 Independent Director
Kevin J. Hobert 58 2021 Independent Director
Elizabeth Kwo 42 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ASXC Comments

Write your thoughts about Asensus Surgical Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ioulios Karakokkinos
Ioulios Karakokkinos Aug 02, 2021 7:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huge potentials
trung huynh
trung huynh Aug 02, 2021 7:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i see nothing.everyday down
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email